Sort
15,440 grants matching “organoids”
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
$285,795Joshua (chuck) Harrell · Virginia Commonwealth University · U54 · FY2023 · CA
Core 1: Animal and Cell Model Core
$285,729Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2023 · CA
Therapeutic implication of RB1 loss in bladder cancer
$285,729Qiang Li · Roswell Park Cancer Institute Corp · K08 · FY2023 · CA
Therapeutic implication of RB1 loss in bladder cancer
$285,729Qiang Li · Roswell Park Cancer Institute Corp · K08 · FY2025 · CA
Therapeutic implication of RB1 loss in bladder cancer
$285,729Qiang Li · Roswell Park Cancer Institute Corp · K08 · FY2024 · CA
Therapeutic implication of RB1 loss in bladder cancer
$285,729Qiang Li · Roswell Park Cancer Institute Corp · K08 · FY2021 · CA
Therapeutic implication of RB1 loss in bladder cancer
$285,729Qiang Li · Roswell Park Cancer Institute Corp · K08 · FY2022 · CA
Pathology Core Facility Shared Resource
$285,637Jian-Jun Wei · Northwestern University At Chicago · P30 · FY2022 · CA
Pathology Core Facility Shared Resource
$285,637Jian-Jun Wei · Northwestern University At Chicago · P30 · FY2020 · CA
Pathology Core Facility Shared Resource
$285,637Jian-Jun Wei · Northwestern University At Chicago · P30 · FY2021 · CA
Pathology Core Facility Shared Resource
$285,637Jian-Jun Wei · Northwestern University At Chicago · P30 · FY2019 · CA
The role of immunosuppression in the tumor microenvironment in Hispanic/Latino patients with breast cancer
$285,605Evanthia Theodosiou Roussos Torres · University Of Southern California · P20 · FY2024 · CA
Proteomics/Metabolism Core
$285,180Birgit Schilling · Buck Institute For Research On Aging · P01 · FY2025 · AG
PHARMACOGENOMIC SIGNATURES THAT PREDICT DRUG RESPONSE AND RESISTANCE IN HIGH-GRADE SEROUS OVARIAN CANCER USING PATIENT-DERIVED ORGANOIDS AND THEIR EXOSOMES
$285,031University Of Oklahoma · · FY2019 · Defense Health Agency
The Role of Airborne PCBs in Adipogenesis, Adipose Function, and Metabolic Syndrome
$284,876Aloysius John Klingelhutz · University Of Iowa · P42 · FY2020 · ES
Administrative Core
$284,853Guo-Li Ming · University Of Pennsylvania · U19 · FY2019 · AI
Identification of Novel Cancer Selective Compounds in 3D Tumor Organoid Assays
$284,744Matthew S Sigman · University Of Utah · R01 · FY2013 · CA
Gene-edited liver organoids for predictive hepatotoxicity
$284,638Pranav Joshi · Bioprinting Laboratories, Inc. · R43 · FY2023 · ES
Core 3: Biospecimens and Pathology Core
$284,568Francisco Vega-Vazquez · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA
Role of genomic and microenvironment factors in conferring acquired resistance to ferroptosis to chemoradiation in esophageal adenocarcinoma
$284,543Steven Hsesheng Lin · University Of Tx Md Anderson Can Ctr · U54 · FY2023 · CA
PDX tumor-TME acquired resistance
$284,529Jack Roth · University Of California, San Francisco · U54 · FY2025 · CA
Regulation of Helicobacter pylori virulence by dietary factors that impact gastric cancer
$283,836Timothy L Cover · Vanderbilt University Medical Center · P01 · FY2025 · CA
Polyamines and Electrophiles in Gastric Cancer
$283,836Keith T Wilson · Vanderbilt University Medical Center · P01 · FY2025 · CA
Effect of Iron Deprivation on H. pylori-induced Gastric Carcinogenesis
$283,836Richard M Peek · Vanderbilt University Medical Center · P01 · FY2025 · CA
Proteomics and Metabolomics
$283,834Kevin L Schey · Vanderbilt University Medical Center · P01 · FY2025 · CA